BusinessAI imageHELP Stock Rises on $35 Barclays Target Before Psychedelic Trial Results
Barclays set a new price target of $35 for HELP stock, suggesting a potential upside of about 150% from its last close near $14. The stock initially surged but then faded ahead of the Q4 psychedelic drug trial results, indicating investor anticipation of the upcoming data.
Asianet Newsable·




